{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,26]],"date-time":"2026-07-26T05:17:55Z","timestamp":1785043075090,"version":"3.55.0"},"reference-count":46,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2021,5,1]],"date-time":"2021-05-01T00:00:00Z","timestamp":1619827200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,5,1]],"date-time":"2021-05-01T00:00:00Z","timestamp":1619827200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2021,5,1]],"date-time":"2021-05-01T00:00:00Z","timestamp":1619827200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2021,5,1]],"date-time":"2021-05-01T00:00:00Z","timestamp":1619827200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2021,5,1]],"date-time":"2021-05-01T00:00:00Z","timestamp":1619827200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2021,5,1]],"date-time":"2021-05-01T00:00:00Z","timestamp":1619827200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2021,5,1]],"date-time":"2021-05-01T00:00:00Z","timestamp":1619827200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100006541","name":"Comunidad de Madrid Consejer\u00eda de Sanidad","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100006541","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004587","name":"Instituto de Salud Carlos III","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100004587","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000780","name":"European Commission","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100000780","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Schizophrenia Research"],"published-print":{"date-parts":[[2021,5]]},"DOI":"10.1016\/j.schres.2021.03.010","type":"journal-article","created":{"date-parts":[[2021,4,7]],"date-time":"2021-04-07T18:40:16Z","timestamp":1617820816000},"page":"100-107","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":10,"special_numbering":"C","title":["The role of depression in the prediction of a \u201clate\u201d remission in first-episode psychosis: An analysis of the OPTiMiSE study"],"prefix":"10.1016","volume":"231","author":[{"given":"David","family":"Fraguas","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Covadonga M.","family":"D\u00edaz-Caneja","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Laura","family":"Pina-Camacho","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Inge","family":"Winter van Rossum","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lone","family":"Baandrup","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Iris E.","family":"Sommer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Birte","family":"Glenth\u00f8j","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ren\u00e9 S.","family":"Kahn","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stefan","family":"Leucht","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Celso","family":"Arango","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.schres.2021.03.010_bb0005","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1016\/0920-9964(90)90005-R","article-title":"A depression rating scale for schizophrenics","volume":"3","author":"Addington","year":"1990","journal-title":"Schizophr. Res."},{"key":"10.1016\/j.schres.2021.03.010_bb0010","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1016\/0920-9964(95)00070-4","article-title":"A psychometric comparison of the Calgary Depression Scale for Schizophrenia and the Hamilton Depression Rating Scale","volume":"19","author":"Addington","year":"1996","journal-title":"Schizophr. Res."},{"key":"10.1016\/j.schres.2021.03.010_bb0015","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1016\/j.schres.2013.12.014","article-title":"Reliability and validity of the Calgary Depression Scale for Schizophrenia (CDSS) in youth at clinical high risk for psychosis","volume":"153","author":"Addington","year":"2014","journal-title":"Schizophr. Res."},{"key":"10.1016\/j.schres.2021.03.010_bb0020","doi-asserted-by":"crossref","first-page":"281","DOI":"10.3109\/10673229.2012.747804","article-title":"Remission in schizophrenia: critical and systematic review","volume":"20","author":"AlAqeel","year":"2012","journal-title":"Harv. Rev. Psychiatry"},{"key":"10.1016\/j.schres.2021.03.010_bb0025","doi-asserted-by":"crossref","first-page":"441","DOI":"10.1176\/appi.ajp.162.3.441","article-title":"Remission in schizophrenia: proposed criteria and rationale for consensus","volume":"162","author":"Andreasen","year":"2005","journal-title":"Am. J. Psychiatry"},{"key":"10.1016\/j.schres.2021.03.010_bb0030","doi-asserted-by":"crossref","first-page":"67","DOI":"10.3389\/fpsyt.2019.00067","article-title":"Predictive factors of treatment resistance in first episode of psychosis: a systematic review","volume":"10","author":"Bozzatello","year":"2019","journal-title":"Front Psychiatry"},{"key":"10.1016\/j.schres.2021.03.010_bb0035","doi-asserted-by":"crossref","first-page":"505","DOI":"10.31887\/DCNS.2014.16.4\/mcarbon","article-title":"Clinical predictors of therapeutic response to antipsychotics in schizophrenia","volume":"16","author":"Carbon","year":"2014","journal-title":"Dialogues Clin. Neurosci."},{"key":"10.1016\/j.schres.2021.03.010_bb0040","doi-asserted-by":"crossref","first-page":"186","DOI":"10.1016\/j.schres.2006.09.027","article-title":"The burden of depressive symptoms in the long-term treatment of patients with schizophrenia","volume":"90","author":"Conley","year":"2007","journal-title":"Schizophr. Res."},{"key":"10.1016\/j.schres.2021.03.010_bb0045","doi-asserted-by":"crossref","first-page":"2063","DOI":"10.1176\/appi.ajp.160.11.2063","article-title":"Early prediction of antipsychotic response in schizophrenia","volume":"160","author":"Correll","year":"2003","journal-title":"Am. J. Psychiatry"},{"key":"10.1016\/j.schres.2021.03.010_bb0050","doi-asserted-by":"crossref","first-page":"1371","DOI":"10.1016\/S0140-6736(12)62129-1","article-title":"Identification of risk loci with shared effects on five major psychiatric disorders: a genome-wide analysis","volume":"381","author":"Cross-Disorder Group of the Psychiatric Genomics Consortium","year":"2013","journal-title":"Lancet"},{"key":"10.1016\/j.schres.2021.03.010_bb0055","doi-asserted-by":"crossref","first-page":"182","DOI":"10.1016\/j.schres.2017.06.029","article-title":"Prevalence, demographic and clinical features of comorbid depressive symptoms in drug naive patients with schizophrenia presenting with first episode psychosis","volume":"193","author":"Dai","year":"2018","journal-title":"Schizophr. Res."},{"key":"10.1016\/j.schres.2021.03.010_bb0060","doi-asserted-by":"crossref","first-page":"602","DOI":"10.1016\/S2215-0366(20)30147-4","article-title":"Effect of delaying treatment of first-episode psychosis on symptoms and social outcomes: a longitudinal analysis and modelling study","volume":"7","author":"Drake","year":"2020","journal-title":"Lancet Psychiatry"},{"key":"10.1016\/j.schres.2021.03.010_bb0065","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1016\/S0920-9964(01)00247-X","article-title":"Validity of the depressive dimension extracted from principal component analysis of the PANSS in drug-free patients with schizophrenia","volume":"56","author":"El Yazaji","year":"2002","journal-title":"Schizophr. Res."},{"key":"10.1016\/j.schres.2021.03.010_bb0070","doi-asserted-by":"crossref","first-page":"1691","DOI":"10.4088\/JCP.10m06349","article-title":"Time to treatment response in first-episode schizophrenia: should acute treatment trials last several months?","volume":"72","author":"Gallego","year":"2011","journal-title":"J. Clin. Psychiatry"},{"key":"10.1016\/j.schres.2021.03.010_bb0075","doi-asserted-by":"crossref","first-page":"686","DOI":"10.1176\/appi.ajp.2009.09060802","article-title":"International consensus study of antipsychotic dosing","volume":"167","author":"Gardner","year":"2010","journal-title":"Am. J. Psychiatry"},{"key":"10.1016\/j.schres.2021.03.010_bb0080","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1016\/j.schres.2016.02.034","article-title":"Subjective quality of life in first-episode psychosis. A ten year follow-up study","volume":"172","author":"Gardsjord","year":"2016","journal-title":"Schizophr. Res."},{"key":"10.1016\/j.schres.2021.03.010_bb0085","doi-asserted-by":"crossref","first-page":"664","DOI":"10.1192\/bjp.165.5.664","article-title":"Prediction of outcome following a first episode of schizophrenia. A follow-up study of Northwick Park first episode study subjects","volume":"165","author":"Geddes","year":"1994","journal-title":"Br. J. Psychiatry"},{"key":"10.1016\/j.schres.2021.03.010_bb0090","doi-asserted-by":"crossref","first-page":"198","DOI":"10.1192\/bjp.bp.116.190520","article-title":"Treatment of depression in schizophrenia: systematic review and meta-analysis","volume":"211","author":"Gregory","year":"2017","journal-title":"Br. J. Psychiatry"},{"key":"10.1016\/j.schres.2021.03.010_bb0095","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1016\/j.psychres.2017.03.018","article-title":"Scales for assessment of depression in schizophrenia: factor analysis of Calgary depression rating scale and Hamilton depression rating scale","volume":"252","author":"Grover","year":"2017","journal-title":"Psychiatry Res."},{"key":"10.1016\/j.schres.2021.03.010_bb0100","series-title":"ECDEU Assessment Manual for Psychopharmacology","author":"Guy","year":"1976"},{"key":"10.1016\/j.schres.2021.03.010_bb0105","doi-asserted-by":"crossref","first-page":"9804836","DOI":"10.1155\/2019\/9804836","article-title":"From onset and prodromal stage to a life-long course of schizophrenia and its symptom dimensions: how sex, age, and other risk factors influence incidence and course of illness","volume":"2019","author":"Hafner","year":"2019","journal-title":"Psychiatry J."},{"key":"10.1016\/j.schres.2021.03.010_bb0110","doi-asserted-by":"crossref","first-page":"216","DOI":"10.1176\/appi.ajp.2016.16050503","article-title":"Treatment-resistant schizophrenia: treatment response and resistance in psychosis (TRRIP) working group consensus guidelines on diagnosis and terminology","volume":"174","author":"Howes","year":"2017","journal-title":"Am. J. Psychiatry"},{"key":"10.1016\/j.schres.2021.03.010_bb0115","doi-asserted-by":"crossref","first-page":"797","DOI":"10.1016\/S2215-0366(18)30252-9","article-title":"Amisulpride and olanzapine followed by open-label treatment with clozapine in first-episode schizophrenia and schizophreniform disorder (OPTiMiSE): a three-phase switching study","volume":"5","author":"Kahn","year":"2018","journal-title":"Lancet Psychiatry"},{"key":"10.1016\/j.schres.2021.03.010_bb0120","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1093\/schbul\/13.2.261","article-title":"The positive and negative syndrome scale (PANSS) for schizophrenia","volume":"13","author":"Kay","year":"1987","journal-title":"Schizophr. Bull."},{"key":"10.1016\/j.schres.2021.03.010_bb0125","doi-asserted-by":"crossref","first-page":"581","DOI":"10.1038\/npp.2009.164","article-title":"Early response to antipsychotic drug therapy as a clinical marker of subsequent response in the treatment of schizophrenia","volume":"35","author":"Kinon","year":"2010","journal-title":"Neuropsychopharmacology."},{"key":"10.1016\/j.schres.2021.03.010_bb0130","series-title":"Psychiatrie. Ein Lehrbuch f\u00fcr Studierende und Aerzte. 6 Auflage. English translation by Metoui, H. ASP, A Textbook for Students and Physicians, 1990","first-page":"1899","author":"Kraepelin","year":"1990"},{"key":"10.1016\/j.schres.2021.03.010_bb0135","doi-asserted-by":"crossref","first-page":"240","DOI":"10.1016\/j.eurpsy.2010.10.007","article-title":"The course of depressive symptoms and prescribing patterns of antidepressants in schizophrenia in a one-year follow-up study","volume":"27","author":"Lako","year":"2012","journal-title":"Eur. Psychiatry"},{"key":"10.1016\/j.schres.2021.03.010_bb0140","doi-asserted-by":"crossref","first-page":"790","DOI":"10.1093\/schbul\/sbv177","article-title":"Initial and progressive gray matter abnormalities in insular gyrus and temporal pole in first-episode schizophrenia contrasted with first-episode affective psychosis","volume":"42","author":"Lee","year":"2016","journal-title":"Schizophr. Bull."},{"key":"10.1016\/j.schres.2021.03.010_bb0145","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0212846","article-title":"Predicting one-year outcome in first episode psychosis using machine learning","volume":"14","author":"Leighton","year":"2019","journal-title":"PLoS One"},{"issue":"Suppl","key":"10.1016\/j.schres.2021.03.010_bb0150","doi-asserted-by":"crossref","first-page":"8","DOI":"10.4088\/JCP.13049su1c.02","article-title":"Measurements of response, remission, and recovery in schizophrenia and examples for their clinical application","volume":"75","author":"Leucht","year":"2014","journal-title":"J. Clin. Psychiatry"},{"key":"10.1016\/j.schres.2021.03.010_bb0155","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1177\/0269881113517956","article-title":"Early improvement as a predictor of treatment response and remission in patients with schizophrenia: a pooled, post-hoc analysis from the asenapine development program","volume":"28","author":"Leucht","year":"2014","journal-title":"J. Psychopharmacol."},{"key":"10.1016\/j.schres.2021.03.010_bb0160","doi-asserted-by":"crossref","first-page":"549","DOI":"10.1093\/schbul\/sbv019","article-title":"The optimization of treatment and management of schizophrenia in Europe (OPTiMiSE) trial: rationale for its methodology and a review of the effectiveness of switching antipsychotics","volume":"41","author":"Leucht","year":"2015","journal-title":"Schizophr. Bull."},{"key":"10.1016\/j.schres.2021.03.010_bb0165","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1093\/schbul\/18.3.351","article-title":"Prospective study of psychobiology in first-episode schizophrenia at Hillside Hospital","volume":"18","author":"Lieberman","year":"1992","journal-title":"Schizophr. Bull."},{"key":"10.1016\/j.schres.2021.03.010_bb0170","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1186\/s12888-015-0629-0","article-title":"Treatment of early non-response in patients with schizophrenia: assessing the efficacy of antipsychotic dose escalation","volume":"15","author":"Loebel","year":"2015","journal-title":"BMC Psychiatry"},{"key":"10.1016\/j.schres.2021.03.010_bb0175","doi-asserted-by":"crossref","first-page":"186","DOI":"10.1002\/ajmg.b.32712","article-title":"Co-shared genetics and possible risk gene pathway partially explain the comorbidity of schizophrenia, major depressive disorder, type 2 diabetes, and metabolic syndrome","volume":"180","author":"Postolache","year":"2019","journal-title":"Am. J. Med. Genet. B Neuropsychiatr. Genet."},{"key":"10.1016\/j.schres.2021.03.010_bb0180","first-page":"674641","article-title":"Depressive symptoms during an acute schizophrenic episode: frequency and clinical correlates","author":"Rajkumar","year":"2015","journal-title":"Depress. Res. Treat."},{"key":"10.1016\/j.schres.2021.03.010_bb0185","doi-asserted-by":"crossref","first-page":"423","DOI":"10.1016\/j.schres.2017.06.056","article-title":"Clinical utility of the Calgary Depression Scale for Schizophrenia in individuals at ultra-high risk of psychosis","volume":"193","author":"Rekhi","year":"2018","journal-title":"Schizophr. Res."},{"key":"10.1016\/j.schres.2021.03.010_bb0190","doi-asserted-by":"crossref","first-page":"502","DOI":"10.1016\/j.jid.2018.12.023","article-title":"Research techniques made simple: interpreting measures of Association in Clinical Research","volume":"139","author":"Roberts","year":"2019","journal-title":"J. Invest. Dermatol."},{"key":"10.1016\/j.schres.2021.03.010_bb0195","doi-asserted-by":"crossref","first-page":"544","DOI":"10.1176\/ajp.156.4.544","article-title":"Predictors of treatment response from a first episode of schizophrenia or schizoaffective disorder","volume":"156","author":"Robinson","year":"1999","journal-title":"Am. J. Psychiatry"},{"key":"10.1016\/j.schres.2021.03.010_bb0200","doi-asserted-by":"crossref","first-page":"617","DOI":"10.1176\/appi.ajp.2015.14101329","article-title":"Early improvement as a predictor of later response to antipsychotics in schizophrenia: a diagnostic test review","volume":"172","author":"Samara","year":"2015","journal-title":"Am. J. Psychiatry"},{"key":"10.1016\/j.schres.2021.03.010_bb0205","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1016\/S0920-9964(02)00490-5","article-title":"Cross-cultural adaptation and validation of the Spanish version of the Calgary Depression Scale for Schizophrenia","volume":"68","author":"Sarro","year":"2004","journal-title":"Schizophr. Res."},{"issue":"Suppl","key":"10.1016\/j.schres.2021.03.010_bb0210","first-page":"22","article-title":"The Mini-International Neuropsychiatric Interview (M.I.N.I.): the development and validation of a structured diagnostic psychiatric interview for DSM-IV and ICD-10","volume":"59","author":"Sheehan","year":"1998","journal-title":"J. Clin. Psychiatry"},{"key":"10.1016\/j.schres.2021.03.010_bb0215","doi-asserted-by":"crossref","first-page":"1485","DOI":"10.1007\/s00787-015-0725-1","article-title":"Early response or nonresponse at week 2 and week 3 predict ultimate response or nonresponse in adolescents with schizophrenia treated with olanzapine: results from a 6-week randomized, placebo-controlled trial","volume":"24","author":"Stentebjerg-Olesen","year":"2015","journal-title":"Eur. Child Adolesc. Psychiatry"},{"key":"10.1016\/j.schres.2021.03.010_bb0220","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1111\/j.1600-0447.2009.01506.x","article-title":"The evolution of depression and suicidality in first episode psychosis","volume":"122","author":"Upthegrove","year":"2010","journal-title":"Acta Psychiatr. Scand."},{"key":"10.1016\/j.schres.2021.03.010_bb0225","first-page":"240","article-title":"Depression and schizophrenia: cause, consequence, or trans-diagnostic issue?","volume":"43","author":"Upthegrove","year":"2017","journal-title":"Schizophr. Bull."},{"key":"10.1016\/j.schres.2021.03.010_bb0230","doi-asserted-by":"crossref","DOI":"10.4088\/JCP.19m12780","article-title":"Sex differences in the prevalence and clinical features of comorbid depressive symptoms in never-treated Chinese patients with first-episode schizophrenia","volume":"80","author":"Wang","year":"2019","journal-title":"J. Clin. Psychiatry"}],"container-title":["Schizophrenia Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0920996421001304?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0920996421001304?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,12]],"date-time":"2025-10-12T19:41:31Z","timestamp":1760298091000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0920996421001304"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,5]]},"references-count":46,"alternative-id":["S0920996421001304"],"URL":"https:\/\/doi.org\/10.1016\/j.schres.2021.03.010","relation":{},"ISSN":["0920-9964"],"issn-type":[{"value":"0920-9964","type":"print"}],"subject":[],"published":{"date-parts":[[2021,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"The role of depression in the prediction of a \u201clate\u201d remission in first-episode psychosis: An analysis of the OPTiMiSE study","name":"articletitle","label":"Article Title"},{"value":"Schizophrenia Research","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.schres.2021.03.010","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}